{"entity":{"type":"insider","cik":"0001735944","url":"/insider/0001735944","json_url":"/insider/0001735944.json","name":"Kewalramani Reshma","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":79,"n_filings":30,"first":"2018-10-09","last":"2026-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Kewalramani Reshma","source":"filing","n_filings":30,"first_seen":"2018-10-09","last_seen":"2026-03-03"}],"transactions":[{"id":5780738,"accession":"0000875320-26-000129","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000875320-26-000129","line_url":"/filing/0000875320-26-000129","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":493.47137125,"price_display":"493.47","price_state":"stated","total_value":19738854.85,"total_display":"19,738,854.85","total_whole":"19,738,855","shares_owned_after":105998.0,"shares_owned_after_display":"105,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-03","scope":"insider","n_lines":13},{"id":5148258,"accession":"0000875320-25-000220","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-25-000220","line_url":"/filing/0000875320-25-000220","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":389.57677,"price_display":"389.58","price_state":"stated","total_value":3895767.7,"total_display":"3,895,767.70","total_whole":"3,895,768","shares_owned_after":115968.0,"shares_owned_after_display":"115,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-08-07","scope":"insider","n_lines":2},{"id":2455423,"accession":"0000875320-24-000225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000225","line_url":"/filing/0000875320-24-000225#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15198.0,"shares_display":"15,198","price_per_share":515.0,"price_display":"515.00","price_state":"stated","total_value":7826970.0,"total_display":"7,826,970.00","total_whole":"7,826,970","shares_owned_after":75772.0,"shares_owned_after_display":"75,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2058806,"accession":"0000875320-24-000195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000195","line_url":"/filing/0000875320-24-000195#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15202.0,"shares_display":"15,202","price_per_share":505.0,"price_display":"505.00","price_state":"stated","total_value":7677010.0,"total_display":"7,677,010.00","total_whole":"7,677,010","shares_owned_after":90970.0,"shares_owned_after_display":"90,970","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-30","filed_date":"2024-08-01","scope":"insider"},{"id":2846202,"accession":"0000875320-24-000187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000187","line_url":"/filing/0000875320-24-000187#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15202.0,"shares_display":"15,202","price_per_share":497.0,"price_display":"497.00","price_state":"stated","total_value":7555394.0,"total_display":"7,555,394.00","total_whole":"7,555,394","shares_owned_after":106172.0,"shares_owned_after_display":"106,172","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-22","filed_date":"2024-07-24","scope":"insider"},{"id":3198106,"accession":"0000875320-24-000160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000875320-24-000160","line_url":"/filing/0000875320-24-000160#line-2","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1565.0,"shares_display":"1,565","price_per_share":457.0,"price_display":"457.00","price_state":"stated","total_value":715205.0,"total_display":"715,205.00","total_whole":"715,205","shares_owned_after":121374.0,"shares_owned_after_display":"121,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-24","filed_date":"2024-05-29","scope":"insider"},{"id":2719278,"accession":"0000875320-24-000156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000156","line_url":"/filing/0000875320-24-000156#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15202.0,"shares_display":"15,202","price_per_share":447.0,"price_display":"447.00","price_state":"stated","total_value":6795294.0,"total_display":"6,795,294.00","total_whole":"6,795,294","shares_owned_after":121374.0,"shares_owned_after_display":"121,374","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider"},{"id":7799330,"accession":"0000875320-23-000062","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000875320-23-000062","line_url":"/filing/0000875320-23-000062#line-3","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17135.0,"shares_display":"17,135","price_per_share":407.0,"price_display":"407.00","price_state":"stated","total_value":6973945.0,"total_display":"6,973,945.00","total_whole":"6,973,945","shares_owned_after":108711.0,"shares_owned_after_display":"108,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-15","filed_date":"2023-12-19","scope":"insider"},{"id":8100247,"accession":"0000875320-23-000058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-23-000058","line_url":"/filing/0000875320-23-000058#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5098.0,"shares_display":"5,098","price_per_share":397.0,"price_display":"397.00","price_state":"stated","total_value":2023906.0,"total_display":"2,023,906.00","total_whole":"2,023,906","shares_owned_after":108711.0,"shares_owned_after_display":"108,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-13","filed_date":"2023-12-15","scope":"insider"},{"id":8527271,"accession":"0000875320-23-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-23-000035","line_url":"/filing/0000875320-23-000035#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5097.0,"shares_display":"5,097","price_per_share":377.0,"price_display":"377.00","price_state":"stated","total_value":1921569.0,"total_display":"1,921,569.00","total_whole":"1,921,569","shares_owned_after":113809.0,"shares_owned_after_display":"113,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-13","filed_date":"2023-11-15","scope":"insider"},{"id":7898676,"accession":"0001209191-23-042557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-042557","line_url":"/filing/0001209191-23-042557#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7828.0,"shares_display":"7,828","price_per_share":355.0,"price_display":"355.00","price_state":"stated","total_value":2778940.0,"total_display":"2,778,940.00","total_whole":"2,778,940","shares_owned_after":118906.0,"shares_owned_after_display":"118,906","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-18","scope":"insider"},{"id":7814787,"accession":"0001209191-23-026270","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-026270","line_url":"/filing/0001209191-23-026270","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3317.0,"shares_display":"3,317","price_per_share":339.07930358757915,"price_display":"339.08","price_state":"stated","total_value":1124726.05,"total_display":"1,124,726.05","total_whole":"1,124,726","shares_owned_after":126690.0,"shares_owned_after_display":"126,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-27","filed_date":"2023-05-01","scope":"insider","n_lines":3},{"id":8390791,"accession":"0001209191-23-005219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-005219","line_url":"/filing/0001209191-23-005219#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":315.05,"price_display":"315.05","price_state":"stated","total_value":3150500.0,"total_display":"3,150,500.00","total_whole":"3,150,500","shares_owned_after":89598.0,"shares_owned_after_display":"89,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-27","scope":"insider"},{"id":6560751,"accession":"0000899243-22-029032","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029032","line_url":"/filing/0000899243-22-029032#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11689.0,"shares_display":"11,689","price_per_share":305.06,"price_display":"305.06","price_state":"stated","total_value":3565846.34,"total_display":"3,565,846.34","total_whole":"3,565,846","shares_owned_after":99598.0,"shares_owned_after_display":"99,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-15","filed_date":"2022-08-17","scope":"insider"},{"id":6167149,"accession":"0000899243-22-024385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-024385","line_url":"/filing/0000899243-22-024385#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11689.0,"shares_display":"11,689","price_per_share":291.3,"price_display":"291.30","price_state":"stated","total_value":3405005.7,"total_display":"3,405,005.70","total_whole":"3,405,006","shares_owned_after":111153.0,"shares_owned_after_display":"111,153","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-24","filed_date":"2022-06-28","scope":"insider"},{"id":5201946,"accession":"0001209191-21-052881","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-052881","line_url":"/filing/0001209191-21-052881","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":195.64916,"price_display":"195.65","price_state":"stated","total_value":1956491.6,"total_display":"1,956,491.60","total_whole":"1,956,492","shares_owned_after":69511.0,"shares_owned_after_display":"69,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-19","filed_date":"2021-08-23","scope":"insider","n_lines":2},{"id":2784154,"accession":"0001209191-20-045935","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-045935","line_url":"/filing/0001209191-20-045935","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2073.0,"shares_display":"2,073","price_per_share":271.20355523396046,"price_display":"271.20","price_state":"stated","total_value":562204.97,"total_display":"562,204.97","total_whole":"562,205","shares_owned_after":27677.0,"shares_owned_after_display":"27,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-06","filed_date":"2020-08-10","scope":"insider","n_lines":5},{"id":2965842,"accession":"0001209191-20-030498","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-20-030498","line_url":"/filing/0001209191-20-030498","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99.0,"shares_display":"99","price_per_share":284.1662626262626,"price_display":"284.17","price_state":"stated","total_value":28132.46,"total_display":"28,132.46","total_whole":"28,132","shares_owned_after":26654.0,"shares_owned_after_display":"26,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-15","filed_date":"2020-05-19","scope":"insider","n_lines":10},{"id":3312533,"accession":"0001209191-20-027885","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-027885","line_url":"/filing/0001209191-20-027885#line-7","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":864.0,"shares_display":"864","price_per_share":274.04,"price_display":"274.04","price_state":"stated","total_value":236770.56,"total_display":"236,770.56","total_whole":"236,771","shares_owned_after":26760.0,"shares_owned_after_display":"26,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-08","scope":"insider"},{"id":3312529,"accession":"0001209191-20-027885","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-027885","line_url":"/filing/0001209191-20-027885#line-6","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":416.0,"shares_display":"416","price_per_share":270.35,"price_display":"270.35","price_state":"stated","total_value":112465.6,"total_display":"112,465.60","total_whole":"112,466","shares_owned_after":28284.0,"shares_owned_after_display":"28,284","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-08","scope":"insider"},{"id":3312518,"accession":"0001209191-20-027885","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-027885","line_url":"/filing/0001209191-20-027885#line-5","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001735944","owner_name":"Kewalramani Reshma","owner_display_name":"Kewalramani Reshma","owner_url":"/insider/0001735944","role":"Director, Officer (CEO & President)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360.0,"shares_display":"360","price_per_share":272.77,"price_display":"272.77","price_state":"stated","total_value":98197.2,"total_display":"98,197.20","total_whole":"98,197","shares_owned_after":27624.0,"shares_owned_after_display":"27,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-06","filed_date":"2020-05-08","scope":"insider"}],"collapsed":true,"next_cursor":"2020-05-06|3312518","ledger_fault":false,"count":{"value":79,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":75,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":79},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Director, Officer (CEO & President)","n_filings":30,"first_seen":"2018-10-09","last_seen":"2026-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001735944","retrieved_at":"2026-08-24T03:53:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}